Announcements Trials
Browse Landscape

Phase

Phase 3 3Phase 2 1

Status

Active not recruiting 2Recruiting 1Completed 1

Sponsor Class

NETWORK 4

Study Type

Interventional 4

Sponsor

Cancer Type

CNS 4

Conditions

Squamous Cell Carcinoma of Head and Neck 13Oropharyngeal Neoplasms 11Lung Neoplasms 9Carcinoma, Non-Small-Cell Lung 9Mouth Neoplasms 8Laryngeal Neoplasms 8Carcinoma 8Urinary Bladder Neoplasms 6Nasopharyngeal Carcinoma 6Hypopharyngeal Neoplasms 6Pancreatic Neoplasms 5Mesothelioma, Malignant 5Uterine Cervical Neoplasms 4Ovarian Neoplasms 4Medulloblastoma 4Ganglioneuroblastoma 4Gallbladder Neoplasms 4Neuroblastoma 3Lymphoid Interstitial Pneumonia 3Cholangiocarcinoma 3Triple Negative Breast Neoplasms 2Salivary Gland Neoplasms 2Paranasal Sinus Neoplasms 2Fallopian Tube Neoplasms 2Colorectal Neoplasms 2Carcinoma, Transitional Cell 2Adenocarcinoma of Lung 2Vulvar Neoplasms 1Vaginal Neoplasms 1Uterine Neoplasms 1

Interventions

Cyclophosphamide 15Temozolomide 11Vincristine 10Magnetic Resonance Spectroscopy 10Cisplatin 10Specimen Handling 8Radiotherapy 8Etoposide 8X-Rays 6Phantoms, Imaging 6Carboplatin 6Nuclear Medicine Department, Hospital 5Lomustine 5Radiation 4Platinum 4Methotrexate 4Irinotecan 4Filgrastim 4Biopsy 41,2-diaminocyclohexaneplatinum II citrate 4etoposide phosphate 3Thiotepa 3Nivolumab 3Granulocyte Colony-Stimulating Factor 3Celecoxib 3Bevacizumab 3Automobiles 3ulixertinib 2tipifarnib 2tazemetostat 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Medulloblastoma × 1,2-diaminocyclohexaneplatinum II citrate × 1 year × Clear all
NCT02724579 2026-05-20

Reduced Craniospinal Radiation Therapy and Chemotherapy in Treating Younger Patients With Newly Diagnosed WNT-Driven Medulloblastoma

Children's Oncology Group

Phase 2 Active not recruiting
45 enrolled
CNS

Medulloblastoma

NCT05382338 2026-05-05

A Study of Treatment for Medulloblastoma Using Sodium Thiosulfate to Reduce Hearing Loss

Children's Oncology Group

Phase 3 Recruiting
225 enrolled
CNS

Medulloblastoma

NCT00336024 2026-01-23

Combination Chemotherapy Followed By Peripheral Stem Cell Transplant in Treating Young Patients With Newly Diagnosed Supratentorial Primitive Neuroectodermal Tumors or High-Risk Medulloblastoma

Children's Oncology Group

Phase 3 Completed
91 enrolled 24 charts
CNS

Medulloblastoma

NCT00392327 2025-06-13

Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed, Previously Untreated, High-Risk Medulloblastoma/PNET

Children's Oncology Group

Phase 3 Active not recruiting
379 enrolled 29 charts
CNS

Medulloblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡